5th Workshop on Viral Dynamics

第五届病毒动力学研讨会

基本信息

项目摘要

PROJECT SUMMARY The 5th Workshop on Viral Dynamics is the single most important conference for the mathematical modeling of viral infections, immune responses, vaccines and antiviral therapies. The 2021 conference will continue this tradition of excellence and cover a wide array of topics including HIV, hepatitis viruses, herpesviruses, influenza, vaccination, and immunity. This year’s workshop will also include a considerable focus on SARS-CoV-2 as an area of new and intense interest, and in particular will have sessions on modeling vaccine responses. The program will include twelve blocks of presentations, with each presentation block comprising four oral presentations (each 20 minutes in duration), followed by 10 minutes of interactive discussion. The program will also include concurrent poster sessions during the lunch breaks, during which attendees can view and discuss posters. The poster session will be facilitated by the highly interactive Sococo virtual conference platform, in which participants can select a particular poster to view and then initiate a discussion with the presenter. A main objective of our conference is to strengthen the training pipeline by engaging early-career trainees and in particular under-represented minorities in the field of viral dynamics modeling. Participation of trainees in the conference will be facilitated in part by the trainee stipend program funded by this R13 conference grant, which will support 10 early-career researchers from across the globe in attending and participating in the workshop.
项目摘要 第五届病毒动力学研讨会是一个最重要的会议的数学建模, 病毒感染、免疫反应、疫苗和抗病毒治疗。2021年的大会将延续这一点 卓越的传统,涵盖广泛的主题,包括艾滋病毒,肝炎病毒,疱疹病毒,流感, 疫苗接种和免疫力。今年的研讨会还将相当关注SARS-CoV-2, 新的和强烈的兴趣领域,特别是将有模拟疫苗反应的会议。的 该计划将包括十二块演示文稿,每个演示块包括四个口头 发言(每次20分钟),然后是10分钟的互动讨论。该计划将 还包括在午餐休息期间同时举行的海报会议,与会者可以在此期间查看和讨论 海报.海报会议将由高度互动的Sococo虚拟会议平台提供便利, 参与者可以选择特定的海报来观看,然后发起与演讲者的讨论。主 我们会议的目标是通过吸引早期职业培训生和 特别是在病毒动力学建模领域代表性不足的少数群体。受训人员参加 会议将部分由R13会议补助金资助的培训生津贴计划提供便利, 将支助来自地球仪各地的10名早期职业研究人员出席和参加讲习班。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joshua Tisdell Schiffer其他文献

Joshua Tisdell Schiffer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joshua Tisdell Schiffer', 18)}}的其他基金

Mathematical modeling of optimal therapeutic combinations for HIV cure
HIV治愈最佳治疗组合的数学模型
  • 批准号:
    10540716
  • 财政年份:
    2019
  • 资助金额:
    $ 0.9万
  • 项目类别:
Intense Validation of a Mathematical Model of Herpes Simplex Virus-2 Pathogenesis
单纯疱疹病毒 2 型发病机制数学模型的强化验证
  • 批准号:
    8434257
  • 财政年份:
    2010
  • 资助金额:
    $ 0.9万
  • 项目类别:
Intense Validation of a Mathematical Model of Herpes Simplex Virus-2 Pathogenesis
单纯疱疹病毒 2 型发病机制数学模型的强化验证
  • 批准号:
    7838589
  • 财政年份:
    2010
  • 资助金额:
    $ 0.9万
  • 项目类别:
Intense Validation of a Mathematical Model of Herpes Simplex Virus-2 Pathogenesis
单纯疱疹病毒 2 型发病机制数学模型的强化验证
  • 批准号:
    8034802
  • 财政年份:
    2010
  • 资助金额:
    $ 0.9万
  • 项目类别:
Intense Validation of a Mathematical Model of Herpes Simplex Virus-2 Pathogenesis
单纯疱疹病毒 2 型发病机制数学模型的强化验证
  • 批准号:
    8220961
  • 财政年份:
    2010
  • 资助金额:
    $ 0.9万
  • 项目类别:
Intense Validation of a Mathematical Model of Herpes Simplex Virus-2 Pathogenesis
单纯疱疹病毒 2 型发病机制数学模型的强化验证
  • 批准号:
    8628030
  • 财政年份:
    2010
  • 资助金额:
    $ 0.9万
  • 项目类别:
Establishing microbial and biochemical thresholds for development and persistence
建立发育和持久性的微生物和生化阈值
  • 批准号:
    8769641
  • 财政年份:
  • 资助金额:
    $ 0.9万
  • 项目类别:

相似海外基金

Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children
用于儿童抗病毒治疗的剂量灵活组合 3D 打印输送系统
  • 批准号:
    10682185
  • 财政年份:
    2023
  • 资助金额:
    $ 0.9万
  • 项目类别:
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial) - An Adaptive Phase II Randomized-Controlled Clinical Trial
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)——适应性 II 期随机对照临床试验
  • 批准号:
    475843
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
    Studentship Programs
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial) - An Adaptive Phase II Randomized-Controlled Clinical Trial
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)——适应性 II 期随机对照临床试验
  • 批准号:
    474485
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
    Studentship Programs
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
  • 批准号:
    10683329
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
  • 批准号:
    10481430
  • 财政年份:
    2022
  • 资助金额:
    $ 0.9万
  • 项目类别:
An interdisciplinary approach towards antiviral therapy discovery
抗病毒疗法发现的跨学科方法
  • 批准号:
    nhmrc : 1196520
  • 财政年份:
    2021
  • 资助金额:
    $ 0.9万
  • 项目类别:
    Investigator Grants
Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapy
应用“组学”方法预测退伍军人在使用直接作用抗病毒疗法治愈 HCV 后的肝失代偿事件和肝细胞癌
  • 批准号:
    10260234
  • 财政年份:
    2021
  • 资助金额:
    $ 0.9万
  • 项目类别:
Applying an 'omics' approach to predict hepatic decompensation events and hepatocellular carcinoma in veterans after HCV cure with direct acting antiviral therapy
应用“组学”方法预测退伍军人在使用直接作用抗病毒疗法治愈 HCV 后的肝失代偿事件和肝细胞癌
  • 批准号:
    10548114
  • 财政年份:
    2021
  • 资助金额:
    $ 0.9万
  • 项目类别:
Disparities in the Diffusion of Direct-Acting Antiviral Therapy for Hepatitis C among Baby Boomers: A Mixed-Methods Study
婴儿潮一代丙型肝炎直接作用抗病毒疗法传播的差异:一项混合方法研究
  • 批准号:
    10400318
  • 财政年份:
    2020
  • 资助金额:
    $ 0.9万
  • 项目类别:
COVID-19 Immunologic Antiviral therapy with Omalizumab (CIAO trial)
使用奥马珠单抗进行 COVID-19 免疫抗病毒治疗(CIAO 试验)
  • 批准号:
    449805
  • 财政年份:
    2020
  • 资助金额:
    $ 0.9万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了